BIOADAPTIVES, INC. Cash And Cash Equivalents At Carrying Value

• BIOADAPTIVES, INC. showed a decrease of -69.4% in Cash And Cash Equivalents At Carrying Value from 2021 to 2022.
• This data is from BIOADAPTIVES, INC.'s annual report (Form 10-K), filed with the SEC on March 31, 2023.
• XBRL data for this metric is available from 2013 to 2022 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q1 2014: $11.5 thousand | Q2 2014: $7.5 thousand | Q3 2014: $37.9 thousand | Q4 2014: $37.9 thousand | Q1 2015: $2.8 thousand | Q2 2015: $12.00 | Q3 2015: $162.00 | Q4 2015: $99.00 | Q1 2016: $139.00 | Q2 2016: $100.00 | Q3 2016: $11.9 thousand | Q4 2017: $360.00 | Q2 2018: $180.5 thousand | Q2 2019: $11.9 thousand | Q3 2019: $155.00 | Q4 2019: $12.3 thousand | Q1 2020: $11.6 thousand | Q2 2020: $4.0 thousand | Q3 2020: $14.4 thousand | Q4 2020: $4.6 thousand | Q1 2021: $24.2 thousand | Q3 2022: $17.9 thousand.
• Over the full 8 years of available data (2013 to 2022), BIOADAPTIVES, INC.'s Cash And Cash Equivalents At Carrying Value has grown by 36.5%.
• Historical annual values: Fiscal year 2022: $25.4 thousand | Fiscal year 2021: $82.9 thousand | Fiscal year 2020: $4.6 thousand | Fiscal year 2019: $12.3 thousand | Fiscal year 2018: $56.2 thousand | Fiscal year 2015: $99.00 | Fiscal year 2014: $37.9 thousand | Fiscal year 2013: $18.6 thousand.
• Data sourced from SEC EDGAR public filings as of August 10, 2026.

Last verified: August 10, 2026